These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34273987)

  • 1. Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects: a prospective placebo-controlled cross-over trial.
    Millischer V; Heinzl M; Faka A; Resl M; Trepci A; Klammer C; Egger M; Dieplinger B; Clodi M; Schwieler L
    J Neuroinflammation; 2021 Jul; 18(1):158. PubMed ID: 34273987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
    J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide-induced changes in the kynurenine pathway and symptoms of sickness behavior in humans.
    Balter LJ; Li X; Schwieler L; Erhardt S; Axelsson J; Olsson MJ; Lasselin J; Lekander M
    Psychoneuroendocrinology; 2023 Jul; 153():106110. PubMed ID: 37075653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered kynurenine pathway metabolism in patients with ankylosing spondylitis.
    Eryavuz Onmaz D; Sivrikaya A; Isik K; Abusoglu S; Albayrak Gezer I; Humeyra Yerlikaya F; Abusoglu G; Unlu A; Tezcan D
    Int Immunopharmacol; 2021 Oct; 99():108018. PubMed ID: 34358860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study.
    Kruse JL; Cho JH; Olmstead R; Hwang L; Faull K; Eisenberger NI; Irwin MR
    Psychoneuroendocrinology; 2019 Nov; 109():104371. PubMed ID: 31325802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.
    Verheyen N; Meinitzer A; Grübler MR; Ablasser K; Kolesnik E; Fahrleitner-Pammer A; Belyavskiy E; Trummer C; Schwetz V; Pieske-Kraigher E; Voelkl J; Alesutan I; Catena C; Sechi LA; Brussee H; Lewinski DV; März W; Pieske B; Pilz S; Tomaschitz A
    Clin Chem Lab Med; 2017 Jun; 55(7):1034-1042. PubMed ID: 28432842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD
    Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM
    Front Immunol; 2020; 11():31. PubMed ID: 32153556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
    Heyes MP; Saito K; Devinsky O; Nadi NS
    Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute administration of ibuprofen increases serum concentration of the neuroprotective kynurenine pathway metabolite, kynurenic acid: a pilot randomized, placebo-controlled, crossover study.
    Savitz J; Ford BN; Kuplicki R; Khalsa S; Teague TK; Paulus MP
    Psychopharmacology (Berl); 2022 Dec; 239(12):3919-3927. PubMed ID: 36271950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal Adipose Tissue Is Associated With Alterations in Tryptophan-Kynurenine Metabolism and Markers of Systemic Inflammation in People With Human Immunodeficiency Virus.
    Gelpi M; Ueland PM; Trøseid M; Mocroft A; Lebech AM; Ullum H; Midttun Ø; Lundgren J; Nielsen SD
    J Infect Dis; 2020 Jan; 221(3):419-427. PubMed ID: 31538186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central levels of tryptophan metabolites in subjects with bipolar disorder.
    Trepci A; Sellgren CM; Pålsson E; Brundin L; Khanlarkhani N; Schwieler L; Landén M; Erhardt S
    Eur Neuropsychopharmacol; 2021 Feb; 43():52-62. PubMed ID: 33339712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Immune System Biomarkers Neopterin and Interleukin-10 Are Strongly Related to Tryptophan Metabolism in Healthy Young Adults.
    Deac OM; Mills JL; Gardiner CM; Shane B; Quinn L; Midttun Ø; McCann A; Meyer K; Ueland PM; Fan R; Lu Z; Brody LC; Molloy AM
    J Nutr; 2016 Sep; 146(9):1801-6. PubMed ID: 27489009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
    Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
    J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder.
    van den Ameele S; van Nuijs AL; Lai FY; Schuermans J; Verkerk R; van Diermen L; Coppens V; Fransen E; de Boer P; Timmers M; Sabbe B; Morrens M
    Bipolar Disord; 2020 Feb; 22(1):59-69. PubMed ID: 31398273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers.
    Dornbierer DA; Boxler M; Voegel CD; Stucky B; Steuer AE; Binz TM; Baumgartner MR; Baur DM; Quednow BB; Kraemer T; Seifritz E; Landolt HP; Bosch OG
    Int J Neuropsychopharmacol; 2019 Oct; 22(10):631-639. PubMed ID: 31504554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.